Healthcare and Pharmaceutical companies in Indonesia face a range of challenges: adherence to evolving government regulations, trade challenges and wide range of commercial disputes. Opportunities exist as well. Growth is possible through strategic acquisitions, joint venture, licensing distribution and supply agreement.

Our lawyers advise pharmaceutical domestics and multinationals on the full range of commercial litigations, intellectual properties and M&A issues across the archipelago. Besides, we have deep connections with relevant national bodies in the pharmaceuticals and healthcare sector.

Our singular focus on understanding our clients' success and long-term strategies sets us apart. We commit to fully understanding our clients' businesses–their financial considerations and risk tolerance, as well as the competitive and regulatory environments in which they operate.